Cook MyoSite

Industry · 12 registered clinical trials — 1 currently recruiting.

Status	Trial	Phase	Started
Withdrawn	Japanese Bridging Study of Autologous Muscle Derived Cells Compared to Placebo for Female Urinary Sphincter Re Stress Urinary Incontinence	Phase 3	2025-06-01
Enrolling By Invitation	Observational Registry for Iltamiocel Compared to Placebo for Urinary Sphincter Repair in Post-surgical Female Stress Urinary Incontinence	—	2025-04-11
Active Not Recruiting	Iltamiocel Compared to Placebo for Chronic Fecal Incontinence in Females With Obstetric Injury Fecal Incontinence	Phase 3	2024-03-21
Active Not Recruiting	Autologous Muscle Derived Cells Compared to Placebo for Urinary Sphincter Repair in Post-surgical Female Stres Stress Urinary Incontinence	Phase 3	2019-04-23
Completed	Autologous Cell Therapy for Stress Urinary Incontinence in Males Following Prostate Surgery Urinary Incontinence, Stress, Urination Disorders	Phase 1 / Phase 2	2015-02-19
Completed	Autologous Muscle Derived Cells for Female Urinary Sphincter Repair Stress Urinary Incontinence	Phase 3	2013-11-21
Completed	Autologous Cell Therapy for Treatment of Fecal Incontinence Fecal Incontinence	Phase 1 / Phase 2	2013-03-28
Completed	Autologous Muscle Derived Cells Female Stress Urinary Incontinence Clinical Study Urinary Incontinence, Stress	Phase 3	2011-11-04
Terminated	Autologous Cell Therapy for Ischemic Heart Failure Ischemic Heart Disease	Phase 1 / Phase 2	2011-02-05
Completed	Autologous Cell Therapy for Female Stress Urinary Incontinence Stress Urinary Incontinence	Phase 2	2010-06-02
Completed	An Investigation of the Safety of 4 Different Doses of Autologous Muscle Derived Cells as Therapy for Stress U Stress Urinary Incontinence, Cell Therapy	Phase 2	2008-10-09
Temporarily Not Available	Expanded Access Program for Autologous Muscle Derived Cells (AMDCs)	—	—